secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stablecoin Development Corp (SDEV)
CIK:        0001389545
Form:       8-K/A
Filed at:   2024-05-31T23:59:59+00:00
Accession:  0001437749-24-018922
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NovaBay reports pro forma Q1 2024 net loss $2.3M after DERMAdoctor sale; 1:35 reverse split
--------------------------------------------------------------------------------

- Pro forma Q1 2024: product revenue $2.6M, net loss from cont. ops $2.3M (vs historical $3.1M).
- FY2023 pro forma: net loss $5.8M (historical $9.6M); revenue reduced $3.6M from discontinued DERMAdoctor.
- 1-for-35 reverse stock split effective May 30, 2024, retroactively applied to pro forma per-share data.
- Cash proceeds from DERMAdoctor sale were $1.07M; pro forma loss on divestiture $0.98M as of Dec 31, 2023.
- Company now solely focused on remaining eye-care operations (Avenova) after divestiture.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1389545/000143774924018922/0001437749-24-018922-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1389545/000143774924018922/nby20240531_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-018922

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer